Evrópusambandið - slóvakíska - EMA (European Medicines Agency)

krka, d.d., novo mesto  - lenalidomide hydrochloride monohydrate - multiple myeloma; lymphoma, follicular - imunosupresíva - multiple myelomalenalidomide krka d. novo mesto as monotherapy is indicated for the maintenance treatment of adult patients with newly diagnosed multiple myeloma who have undergone autologous stem cell transplantation. lenalidomide krka d. novo mesto as combination therapy with dexamethasone, or bortezomib and dexamethasone, or melphalan and prednisone (see section 4. 2) je indikovaný na liečbu dospelých predtým neliečených pacientov s myelómom je mladších, ktorí nie sú spôsobilí na transplantáciu. lenalidomide krka d. novo mesto in combination with dexamethasone is indicated for the treatment of multiple myeloma in adult patients who have received at least one prior therapy. follicular lymphomalenalidomide krka d. novo mesto in combination with rituximab (anti-cd20 antibody) is indicated for the treatment of adult patients with previously treated follicular lymphoma (grade 1 – 3a). multiple myelomalenalidomide krka d. novo mesto as monotherapy is indicated for the maintenance treatment of adult patients with newly diagnosed multiple myeloma who have undergone autologous stem cell transplantation. lenalidomide krka d. novo mesto as combination therapy with dexamethasone, or bortezomib and dexamethasone, or melphalan and prednisone (see section 4. 2) je indikovaný na liečbu dospelých predtým neliečených pacientov s myelómom je mladších, ktorí nie sú spôsobilí na transplantáciu. lenalidomide krka d. novo mesto in combination with dexamethasone is indicated for the treatment of multiple myeloma in adult patients who have received at least one prior therapy. follicular lymphomalenalidomide krka d. novo mesto in combination with rituximab (anti-cd20 antibody) is indicated for the treatment of adult patients with previously treated follicular lymphoma (grade 1 – 3a).

Slóvakía - slóvakíska - myHealthbox

bayer ag - stabilná suspenzia - penflufen 100 g/l; prothioconazole 18 g

Evrópusambandið - slóvakíska - EMA (European Medicines Agency)

bayer ag - damoctocog alfa pegol - hemofília a - antihemoragiká - liečba a profylaxia krvácania v minulosti liečených pacientov ≥ 12 rokov s haemophilia a (vrodený faktor viii nedostatok).

Slóvakía - slóvakíska - ŠÚKL (Štátny ústav pre kontrolu liečiv)

imaxeon, pty ltd unit 1, 38-46 south st. nsw 2116 rydalmere austrália -

Slóvakía - slóvakíska - ŠÚKL (Štátny ústav pre kontrolu liečiv)

imaxeon, pty ltd unit 1, 38-46 south st. nsw 2116 rydalmere austrália -

Slóvakía - slóvakíska - ŠÚKL (Štátny ústav pre kontrolu liečiv)

krka, d.d., novo mesto, slovinsko - duloxetín - 30 - antidepressiva

Slóvakía - slóvakíska - ŠÚKL (Štátny ústav pre kontrolu liečiv)

krka, d.d., novo mesto, slovinsko - duloxetín - 30 - antidepressiva

Slóvakía - slóvakíska - ŠÚKL (Štátny ústav pre kontrolu liečiv)

stada arzneimittel ag, nemecko - pregabalín - 21 - antiepileptica, anticonvulsiva

Slóvakía - slóvakíska - ŠÚKL (Štátny ústav pre kontrolu liečiv)

stada arzneimittel ag, nemecko - pregabalín - 21 - antiepileptica, anticonvulsiva

Slóvakía - slóvakíska - ŠÚKL (Štátny ústav pre kontrolu liečiv)

stada arzneimittel ag, nemecko - pregabalín - 21 - antiepileptica, anticonvulsiva